Financials

News Ideas Technicals Forecast

4114 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of SYNMOSA BIOPHARMA CORP

Total assets of 4114 for Q4 23 is 11.73 B TWD, 3.47% more than the previous Q3 23. And total liabilities decreased by 0.53% in Q4 23 to 3.63 B TWD.

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: TWD

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—